Metabolic reprogramming of immune cells by mitochondrial division inhibitor-1 to prevent post-vascular injury neointimal hyperplasia
-
Published:2024-03
Issue:
Volume:390
Page:117450
-
ISSN:0021-9150
-
Container-title:Atherosclerosis
-
language:en
-
Short-container-title:Atherosclerosis
Author:
Crespo-Avilan Gustavo E.,
Hernandez-Resendiz Sauri,
Ramachandra Chrishan J.,
Ungureanu Victor,
Lin Ying-Hsi,
Lu Shengjie,
Bernhagen Jürgen,
El Bounkari Omar,
Preissner Klaus T.,
Liehn Elisa A.,
Hausenloy Derek J.ORCID
Reference98 articles.
1. Global overview of the epidemiology of atherosclerotic cardiovascular disease;Barquera;Arch. Med. Res.,2015
2. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis, JACC;Inoue;Cardiovascular interventions,2011
3. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease;Rocha-Singh;Catheter Cardiovasc Interv,2007
4. Calcium, ATP, and ROS: a mitochondrial love-hate triangle;Brookes;Am J Physiol Cell Physiol,2004
5. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics;Campello;J. Exp. Med.,2006